Sean Whooley

Eli Lilly (NYSE:LLY) today announced plans to invest more than $3.5 billion to build a new manufacturing plant in Pennsylvania. The site, in Lehigh Valley, will serve as the company’s newest injectable medicine and device manufacturing facility. Indianapolis-based Lilly plans to produce next-generation weight-loss therapies there, including retatrutide, a first-in-class investigational GIP, GLP-1 and glucagon…

Cellares announced that it raised $257 in a Series D financing round to support its pharmaceutical manufacturing efforts. The South San Francisco, California-based integrated development and manufacturing organization (IDMO) had its round co-led by BlackRock and Eclipse. It said the funds bring its total capital raised to $612 million to date. Additional investors included accounts…

Pharmaceutical ingredient manufacturer Antheia announced today that it completed a second close of its Series C financing. The company added $24 million to the Series C round, bringing the total round to $80 million. It announced the first close of $56 million in funding in June 2025. Combined with additional capital and non-dilutive funding, including through…

Apiject announced today that it signed a lease on a 30,000-square-foot pharmaceutical manufacturing facility in Apex, North Carolina. The injection delivery system developer plans for the new facility to house two advanced blow-fill-seal (BFS) production lines and serve as an outsourcing facility focused on producing essential generic injectable medicines currently on the FDA’s drug shortage…

BD (NYSE:BDX) announced today that it invested $110 million to expand its production of prefillable syringes in Columbus, Nebraska. Franklin Lakes, New Jersey–based BD aims to expand prefillable syringe production to accelerate biologic and GLP-1 drug delivery and support pharmaceutical reshoring in the U.S. The investment brings the company’s Neopak glass prefillable syringe production to…

Johnson & Johnson (NYSE:JNJ) is expanding in Wilson County, North Carolina, with a new multibillion-dollar pharmaceutical facility. The company expects to create up to 500 new jobs in the community through the project in Wilson. It marks the second time in 14 months that J&J has announced a significant project in the area after a…

Samsung Biologics announced today that it agreed to acquire 100% of Human Genome Sciences from GSK. The acquisition secures Samsung Biologics’ first U.S.-based manufacturing site, located in Rockville, Maryland. It helps to expand the company’s global footprint and commitment to the U.S. market following its transition to become a pure-play CDMO. GSK’s Rockville facility encompasses…

Chitose announced today that it entered into a new partnership with Fujifilm Biosciences to advance biopharmaceutical production. According to a news release, the alliance aims to leverage the strengths of both companies to produce higher-quality biopharmaceutical products. Chitose brings expertise in cell line development, using the established CHO-MK cells. The company said this aligns with…

Novartis announced today that it broke ground on its more than 700,000-square-foot flagship manufacturing hub in North Carolina. The company said it is rapidly moving to construct its recently announced $771 million investment in the state. Its project features a new facility in Morrisville and a new site in Durham, encompassing two new facilities. The…

Eli Lilly (NYSE:LLY) announced that it plans to invest more than $6 billion in a new manufacturing facility in Huntsville, Alabama. The next-generation synthetic medicine active pharmaceutical ingredient (API) facility marks the third of four new U.S. sites. It follows the new facilities announced in Virginia and Texas. Eli Lilly plans for the plant to produce small-molecule…